InsiderSignalSign in

← Insider buys

David Pendarvis has bought stock on 3 days since Apr 2024

Director at WD-40 Company, and 1 other company

SEC CIK 0001196723 · Filings on SEC.gov ↗

$284KBought

$40.3MSold

Feb 6Last buy

David Pendarvis's record

3 months after each buy, from the first price a copier could get.

+4.1%Average

−2.1 ptsVs S&P 500

2 of 3Higher

3 buys since 2024 with 3 months of prices.

Companies

Every filing

92 filings since Jan 2016, newest first

Resmed Inc

Chief Administrative Officer

$498K−4.0%Jun 4

Resmed Inc

Chief Administrative Officer

$492K−4.0%May 7

Resmed Inc

Chief Administrative Officer

$469K−4.0%Apr 5

Resmed Inc

Chief Administrative Officer

$462K−4.0%Mar 5

Resmed Inc

Chief Administrative Officer

$417K−4.0%Feb 5

Resmed Inc

Chief Administrative Officer

$494K−4.0%Jan 4

Resmed Inc

Chief Administrative Officer

$499K−4.0%Dec 6

Resmed Inc

Chief Administrative Officer

$298K−3.0%Nov 6

Resmed Inc

Chief Administrative Officer

$320K−3.0%Oct 4

Resmed Inc

Chief Administrative Officer

$313K−3.0%Sep 5

Resmed Inc

Chief Administrative Officer

$298K−3.0%Aug 6

Resmed Inc

Chief Administrative Officer

$292K−3.0%Jul 5

Resmed Inc

Chief Administrative Officer

$292K−3.0%Jun 4

Resmed Inc

Chief Administrative Officer

$270K−3.0%May 4

Resmed Inc

Chief Administrative Officer

$270K−3.0%Apr 4

Resmed Inc

Chief Administrative Officer

$264K−3.0%Mar 7

Resmed Inc

Chief Administrative Officer

$270K−3.0%Feb 6

Resmed Inc

Chief Administrative Officer

$240K−3.0%Jan 4

Resmed Inc

Chief Administrative Officer

$236K−3.0%Dec 5

Resmed Inc

Chief Administrative Officer

$523K−6.0%Nov 6

Resmed Inc

Chief Administrative Officer

$490K−7.0%Oct 5

Resmed Inc

Chief Administrative Officer

$491K−7.0%Sep 6

Resmed Inc

Chief Administrative Officer

$459K−8.0%Aug 4

Resmed Inc

Chief Administrative Officer

$492K−8.0%Jul 5

Resmed Inc

Chief Administrative Officer

$462K−8.0%Jun 6

Resmed Inc

Chief Administrative Officer

$443K−8.0%May 5

Resmed Inc

Chief Administrative Officer

$456K−8.0%Apr 4

Resmed Inc

Chief Administrative Officer

$460K−8.0%Mar 6

Resmed Inc

Chief Administrative Officer

$427K−8.0%Feb 6

Resmed Inc

Chief Administrative Officer

$394K−8.0%Jan 4

Resmed Inc

Chief Administrative Officer

$382K−8.0%Dec 6

Resmed Inc

Chief Administrative Officer

$349K−7.0%Nov 7

Resmed Inc

Chief Administrative Officer

$384K−7.0%Oct 4

Resmed Inc

Chief Administrative Officer

$403K−7.0%Sep 8

Resmed Inc

Chief Administrative Officer

$413K−7.0%Aug 5

Resmed Inc

Chief Administrative Officer

$382K−7.0%Jul 6

Resmed Inc

Chief Administrative Officer

$356K−7.0%Jun 6

Resmed Inc

Chief Administrative Officer

$336K−7.0%May 5

Resmed Inc

Chief Administrative Officer

$352K−7.0%Apr 5

Resmed Inc

Chief Administrative Officer

$344K−7.0%Mar 7

Resmed Inc

Chief Administrative Officer

$345K−7.0%Feb 5

Resmed Inc

Chief Administrative Officer

$313K−7.0%Jan 5

About David Pendarvis

David B. Pendarvis is a seasoned executive and corporate director, currently serving as Director on the Board of WD-40 Company (NASDAQ: WDFC), a position he has held since his election in December 2017.( As a board member, he contributes to the Audit Committee and Compensation Committee, bringing expertise in legal and administrative matters.( He owns approximately 5,862 shares of WDFC stock, valued at over $1 million.(

Pendarvis served as Chief Administrative Officer, Global General Counsel, and Secretary at ResMed Inc. from 2011 to 2023, overseeing key administrative and legal functions.( Previously, he was a director at Sequenom, Inc. from 2009 until its acquisition by Laboratory Corporation of America Holdings in 2016.( At age 64 (as of 2022), Pendarvis demonstrates deep experience in corporate governance and legal strategy across healthcare and manufacturing sectors.(

Written by Perplexity from public sources.

Filings come from SEC EDGAR. Not investment advice.